Ray Therapeutics

Berkeley, CA · Founded 2021 · Privately Held (backing)

Developer of optogenetic gene therapies designed for vision restoration purposes. Ray Therapeutics is based in Berkeley, CA and was founded in 2021. It has raised $106 million across 2 recorded rounds; the latest was a $14 million early-stage round in May 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$106.0M
Last round
Early Stage VC
May 2023

Who backs Ray Therapeutics?

7 investors
InvestorType
NorwestVenture capital
Novo HoldingsOther
Deerfield ManagementVenture capital
PlatanusFamily office
4BIO Capital—
California Institute for Regenerative Medicine—
MRL Ventures Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ray Therapeutics investors

7 investors are on record for Ray Therapeutics, including Norwest, Novo Holdings, Deerfield Management and Platanus. The early-stage round in May 2023 drew 13 investors.

Free account
More of Ray Therapeutics with a free account
  • ·Watch Ray Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Ray Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View